Your browser doesn't support javascript.
loading
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells.
Chen, Hongmei; Cong, Xiuxiu; Wu, Chenxi; Wu, Xuan; Wang, Jialiang; Mao, Kuirong; Li, Jie; Zhu, Ge; Liu, Feiqi; Meng, Xiandi; Song, Jia; Sun, Xu; Wang, Xin; Liu, Shuhan; Zhang, Shi; Yang, Xianzhu; Song, Yanqiu; Yang, Yong-Guang; Sun, Tianmeng.
Afiliación
  • Chen H; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Cong X; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, China.
  • Wu C; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Wu X; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, China.
  • Wang J; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Mao K; Institute of Translational Medicine, China Medical University, Liaoning, China.
  • Li J; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Zhu G; International Center of Future Science, Jilin University, Changchun, Jilin, China.
  • Liu F; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Meng X; International Center of Future Science, Jilin University, Changchun, Jilin, China.
  • Song J; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, China.
  • Sun X; Institutes for Life Sciences and School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
  • Wang X; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Liu S; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, China.
  • Zhang S; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Yang X; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, China.
  • Song Y; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
  • Yang YG; National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin, China.
  • Sun T; Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin, China.
Sci Adv ; 6(5): eaax4690, 2020 01.
Article en En | MEDLINE | ID: mdl-32064335

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimiocinas CC / ARN Interferente Pequeño / Antígeno CD47 / Receptores CCR / Neoplasias de la Mama Triple Negativas Límite: Animals / Female / Humans Idioma: En Revista: Sci Adv Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimiocinas CC / ARN Interferente Pequeño / Antígeno CD47 / Receptores CCR / Neoplasias de la Mama Triple Negativas Límite: Animals / Female / Humans Idioma: En Revista: Sci Adv Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos